Price T Rowe Associates Inc Vericel Corp Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Vericel Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 41,493 shares of VCEL stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,493

Previous 36,964 12.25%

Holding current value

$1.44 Million

Previous $1.65 Million 7.03%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$37.92 - $45.7 $171,739 - $206,975	4,529 Added 12.25%	41,493 $1.77 Million
Q1 2025 May 14, 2025	BUY	$44.5 - $61.8 $333,082 - $462,573	7,485 Added 25.39%	36,964 $1.65 Million
Q4 2024 Feb 14, 2025	SELL	$40.05 - $59.11 $34,763 - $51,307	-868 Reduced 2.86%	29,479 $1.62 Million
Q3 2024 Nov 14, 2024	BUY	$42.25 - $53.56 $52,601 - $66,682	1,245 Added 4.28%	30,347 $1.28 Million
Q2 2024 Aug 14, 2024	BUY	$41.71 - $52.9 $75,995 - $96,383	1,822 Added 6.68%	29,102 $1.34 Million
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $55,966 - $90,059	1,721 Added 6.73%	27,280 $1.42 Million
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $5,244 - $6,305	170 Added 0.67%	25,559 $911,000
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $86,989 - $107,741	2,745 Added 12.12%	25,389 $852,000
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $16,327 - $21,602	563 Added 2.55%	22,644 $851,000
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $20,081 - $26,388	842 Added 3.96%	22,081 $648,000
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $10,519 - $16,312	596 Added 2.89%	21,239 $559,000
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $70,054 - $100,776	3,097 Added 17.65%	20,643 $479,000
Q2 2022 Aug 15, 2022	SELL	$22.88 - $39.45 $52,784 - $91,011	-2,307 Reduced 11.62%	17,546 $442,000
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $50,006 - $68,311	1,578 Added 8.63%	19,853 $759,000
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $130,908 - $195,619	-3,719 Reduced 16.91%	18,275 $718,000
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $151,518 - $195,322	3,269 Added 17.46%	21,994 $1.07 Million
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $35,777 - $51,399	758 Added 4.22%	18,725 $983,000
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $555,719 - $1.07 Million	17,967 New	17,967 $998,000

Others Institutions Holding VCEL

# of Institutions

294

Shares Held

54M

Call Options Held

35.6K

Put Options Held

7.7K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.64B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Vericel Corp Transaction History